ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166588 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166588; 2) Community: the network communities that were significantly associated with the response to NSC 166588; 3) Molecule: the relationships between components within communities and NSC 166588; 4) MDR: the compounds that were significantly associated with the NSC 166588.

NSC Compound Enrichment Correlation
NSC 724779 1-{[(1R,4S,5R,8S,12R,13R)-1,5-dimethyl-10-(trifluoromethyl)- 11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9- en-9-yl]methyl}-4-{[1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(tr ifluoromethyl)-1 0.00411343439683531 0.41000912
NSC 732122 2-[3-(Benzothiazol-2-ylsulfanyl)-3-(4-methoxy-phenyl)-allyli dene]-malononitrile 0.00411343439683531 0.15435593
NSC 733901 Null 0.00411343439683531 0.19016261
NSC 735212 Null 0.00411343439683531 0.24541947
NSC 114512 Null 0.00423163567577548 0.42141455
NSC 189793 Streptovaricin complex, fraction a 0.00423163567577551 0.48971035
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.00423163567577551 0.32786832
NSC 349644 CYANOCYCLINE A (CHUGAI) 0.00423163567577551 0.57365687
NSC 54909 Propan-1-one, 2,3-dichloro-1,3-bis(4-methylphenyl)- 0.00423163567577551 0.55223684
NSC 619961 Primaquine diphosphate 0.00423163567577551 0.49059151
Total:144  Current:33    [First] [Prev] [Next] [Last]